DIA 2013 49th Annual Meeting
Click here to go to the previous page
Towards an Effective Virtual R&D Team for Faster Accessing of the East Asian Market
Track : Track 03: Innovative Partnering Models and Outsourcing Strategies
Program Code: 344
Date: Wednesday, June 26, 2013
Time: 1:45 PM to 3:15 PM  EST
Location: 102AB
CHAIR :
 Deborah Chee, MD,PhD,MBA (SCHNON), Medical Director, AbbVie Korea Ltd., Republic of Korea
SPEAKER (S):
 Chris Bruenger, MD (SPKNON), President and CEO, IDEC Inc., Japan
Howard Lee, MD,PhD (SPKSUP), Professor, Department of Clinical Pharmacology and Therapeutics, Seoul National University Hospital, Republic of Korea
 Philip Bonasia, PhD (SPKNON), Executive Director and Head, Chemistry and Pharmaceutical Sciences, Sunovion Pharmaceuticals Inc., United States
Description
Strategic use of a "virtual" R&D team model could benefit companies that have limited capabilities in East Asian markets - including Japan, China, Korea and Taiwan - to minimize the drug lag and to maximize product value in these markets.